Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.
This report contains market size and forecasts of Neuroendocrine Tumor Treatment in Global, including the following market information:
Global Neuroendocrine Tumor Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neuroendocrine Tumor Treatment market was valued at 1538.6 million in 2021 and is projected to reach US$ 2260 million by 2028, at a CAGR of 5.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Everolimus Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuroendocrine Tumor Treatment include Exelixis, Inc., Advanced Accelerator Applications, Dauntless Pharmaceuticals, Inc., Hutchinson Medipharma Limited, Ispen, Novartis AG, Progenics Pharmaceuticals, Inc. and Tarveda Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuroendocrine Tumor Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroendocrine Tumor Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neuroendocrine Tumor Treatment Market Segment Percentages, by Type, 2021 (%)
Everolimus
Sunitinib
Lu-Dotatate
Lanreotide
Octreotide
Global Neuroendocrine Tumor Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neuroendocrine Tumor Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Neuroendocrine Tumor Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neuroendocrine Tumor Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuroendocrine Tumor Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neuroendocrine Tumor Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Exelixis, Inc.
Advanced Accelerator Applications
Dauntless Pharmaceuticals, Inc.
Hutchinson Medipharma Limited
Ispen
Novartis AG
Progenics Pharmaceuticals, Inc.
Tarveda Therapeutics